Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (FY)Jan 31, 2025 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (FY)Jan 31, 2023 | (FY)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.11B | 19.62%18.35B | 4.25B | 5.32B | 17.18%15.34B | 3.53B | 3.88B | 14.23%13.09B | 11.46B |
| Cost of revenue | 2.73B | 18.59%10.21B | 2.33B | 3.1B | 16.99%8.61B | 1.97B | 2.12B | 12.55%7.36B | 6.54B |
| Gross profit | 2.38B | 20.94%8.14B | 1.91B | 2.21B | 17.42%6.73B | 1.57B | 1.76B | 16.47%5.73B | 4.92B |
| Operating expense | 1.97B | 14.00%6.77B | 1.65B | 1.66B | 14.76%5.93B | 1.49B | 1.53B | 10.00%5.17B | 4.7B |
| Operating profit | 405.91M | 72.62%1.38B | 258.92M | 553.04M | 41.92%797.01M | 71.3M | 229.59M | 154.07%561.6M | 221.04M |
| Net non-operating interest income (expenses) | 1.98M | 135.35%3.37M | 816K | 613K | -924.76%-9.53M | -6.21M | -4.22M | 13.12%1.16M | 1.02M |
| Non-operating interest income | --1.99M | 48.65%3.41M | --816K | --656K | 62.12%2.29M | --591K | --603K | 30.06%1.42M | --1.09M |
| Non-operating interest expense | --8K | -83.52%43K | --0 | --43K | 0.38%261K | --15K | --46K | 288.06%260K | --67K |
| Total other finance cost | ---- | ---- | ---- | ---- | --11.56M | --6.78M | ---- | ---- | ---- |
| Net investment income | -5.27M | -136.24%-7.09M | 2.54M | -7.15M | 12.60%19.57M | 7.82M | 4.02M | 282.06%17.38M | -9.55M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | -226.06%-11.07M | -8.52M | 113.78%8.78M | 4.11M | ||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | |||||||||
| Special income (charges) | -81.57%-24.52M | 23.51%-13.5M | 71.05%-17.65M | -60.98M | |||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --492K |
| Less:Write off | ---- | 81.57%24.52M | ---- | ---- | -23.51%13.5M | ---- | ---- | -70.81%17.65M | --60.48M |
| Other non-operating income (expenses) | 6.41M | 64.10%14.3M | 2.21M | 2.38M | -59.23%8.71M | 2.98M | -291K | -65.16%21.37M | 61.33M |
| Income before tax | 405.98M | 72.13%1.36B | 264.48M | 548.89M | 33.50%791.19M | 53.88M | 226.55M | 173.13%592.63M | 216.98M |
| Income tax | 142.51M | 59.97%463.62M | 119.89M | 183.75M | 62.18%289.82M | 8.75M | 103.89M | 129.24%178.7M | 77.96M |
| Net income | 263.47M | 79.16%898.25M | 144.59M | 365.14M | 21.12%501.37M | 45.13M | 122.66M | 197.75%413.93M | 139.02M |
| Net income continuous operations | --263.47M | 79.16%898.25M | --144.59M | --365.14M | 21.12%501.37M | --45.13M | --122.66M | 197.75%413.93M | --139.02M |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | 263.47M | 79.16%898.25M | 144.59M | 365.14M | 21.12%501.37M | 45.13M | 122.66M | 197.75%413.93M | 139.02M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 263.47M | 79.16%898.25M | 144.59M | 365.14M | 21.12%501.37M | 45.13M | 122.66M | 197.75%413.93M | 139.02M |
| Gross dividend payment | |||||||||
| Basic earnings per share | 95.96 | 41.57%328.58 | 52.92 | 133.62 | 12.14%232.09 | 3.968 | 61.329 | 197.75%206.966 | 69.5105 |
| Diluted earnings per share | 93.57 | 41.79%320.53 | 51.64 | 130.86 | 9.23%226.06 | 3.968 | 47.1762 | 287.07%206.966 | 53.4696 |
| Dividend per share | 0 | 78.38%66 | 0 | 0 | 37 | 37 | |||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |